Search

everythinglearnresearchcommunity

for

Search:↓

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Precocious puberty is starting earlier due to factors like obesity and chemicals, with treatment focusing on preserving height and addressing social issues.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

More research is needed to understand chemotherapy-induced hair loss and its phases.